Vertex Pharmaceuticals (MEX:VRTX) Land And Improvements: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VRTX Vertex Pharmaceuticals Inc MEX:VRTX
88 GF Score
Price MXN9,410.00
GF Value MXN8,987.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Vertex Pharmaceuticals Land And Improvements?

Vertex Pharmaceuticals MEX:VRTX 88 Land And Improvements is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:VRTX with a GF Score™ of 88/100 and a GF Value™ of MXN8,987.77 (Fairly Valued). The stock has 5 warning signs investors should review.

Vertex Pharmaceuticals's land and improvements for the quarter that ended in Jun. 2026 was MXN0 Mil.

Vertex Pharmaceuticals's quarterly land and improvements declined from Dec. 2025 (MXN596 Mil) to Mar. 2026 (MXN0 Mil) but then stayed the same from Mar. 2026 (MXN0 Mil) to Jun. 2026 (MXN0 Mil).

Vertex Pharmaceuticals's annual land and improvements increased from Dec. 2023 (MXN562 Mil) to Dec. 2024 (MXN690 Mil) but then declined from Dec. 2024 (MXN690 Mil) to Dec. 2025 (MXN596 Mil).

Vertex Pharmaceuticals Land And Improvements Historical Data

* Premium members only.

The historical data trend for Vertex Pharmaceuticals's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vertex Pharmaceuticals Land And Improvements Chart

Vertex Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 679.01 645.32 561.85 690.32 595.99

Vertex Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 595.99 0.00 0.00
MEX:VRTX
88GF Score
Vertex Pharmaceuticals Inc MEX:VRTX
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vertex Pharmaceuticals Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of MXN0 Mil mean?
Vertex Pharmaceuticals (MEX:VRTX) has a Land And Improvements of MXN0 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Vertex Pharmaceuticals and its competitors.
Is Vertex Pharmaceuticals' Land And Improvements too high?
Vertex Pharmaceuticals' current Land And Improvements is MXN0 Mil. Overall, Vertex Pharmaceuticals has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vertex Pharmaceuticals' Land And Improvements compare to REGN and RVMD?
Vertex Pharmaceuticals' Land And Improvements of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Biotechnology company?
A good Land And Improvements depends on the Biotechnology industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Vertex Pharmaceuticals and its competitors. Vertex Pharmaceuticals's current Land And Improvements is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vertex Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Vertex Pharmaceuticals (MEX:VRTX) is currently considered Fairly Valued. The stock's GF Value™ is MXN8,987.77, compared to a current price of MXN9,410.00 — trading 4.7% above its estimated fair value. The current Land And Improvements is MXN0 Mil. Vertex Pharmaceuticals' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Vertex Pharmaceuticals (MEX:VRTX), the current Land And Improvements is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vertex Pharmaceuticals (MEX:VRTX) Overvalued in 2026?

Based on GuruFocus' analysis, Vertex Pharmaceuticals stock appears to be overvalued. The current stock price of MXN9,410.00 is trading 4.7% above its estimated GF Value™ of MXN8,987.77. GuruFocus considers Vertex Pharmaceuticals to be Fairly Valued.

Key valuation signals for MEX:VRTX:

  • Land And Improvements: MXN0 Mil
  • GF Value™: MXN8,987.77 vs. price of MXN9,410.00 (4.7% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the MEX:VRTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vertex Pharmaceuticals Business Description

Address 50 Northern Avenue, Boston, MA, USA, 02210
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
88GF Score

Get the complete analysis for MEX:VRTX

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN9,410.00
Price
MXN8,987.77
GF Value